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Pathophysiology of Human Papillomavirus (HPV)
Kara Shroff, BA, BSN, RN
What is HPV?
• HPV is the most common 
sexually transmitted virus
and can result in various   
types of cancer in both men  
and/or anogenital warts in   
both men and women
• It can be transmitted 
through intimate skin to 
skin contact and primarily 
vaginal and anal 
intercourse (cdc.gov)
• 14 million men and women 
are affected yearly in the 
US (Valentino & Poronsky, 
2015, p. 155).
• There are over 100 strains 
of the virus, but ”13 
oncogenic HPV types can 
progress to precancer or 
cancer” (Viens et al., 2016, 
p. 661), with HPV 16 as the 
mostly likely strain to 
progress to cancer (Viens et 
al, 2016).
• HPV 16 and 18 cause the 
majority of cervical, penile 
and vulvar cancers 
(McCancer & Huether, 
2014, p. 424).
• Non-oncogenic, low risk 
strains, HPV 6 and 11, cause 
most of the genital wart 
cases (Bloem et al, 2017).
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Prevention
.
Risk Factors 
• Half of all sexually active 
people will contract HPV at 
some point in their lifetime 
(McCance & Huether, 2014, 
p. 423).
• Risk factors include 
unprotected intercourse, 
numerous sexual partners 
and age at first intercourse. 
• Teens that are sexually 
active and “young adult 
females are at a higher risk” 
(Valentino & Poronsky, 
2015, p 155) of contracting 
the virus, than women and 
men over 25. 
• Those that are  
immunocompromised, such 
as young adults with HIV.
• Smokers have higher rates 
of HPV infection
• Contracting herpes or 
chlamydia increases the risk 
of HPV infection “due to 
inflammation of the 
epithelial cells and breaks 
in the epithelial layer that 
allows a pathway for HPV 
introduction” (Choma & 
McKeever, 2015, p. 52)..
• The main catalyst for a 
patient receiving the HPV 
vaccine is “a strong provider 
recommendation” 
(Valentino & Poronsky, 
2015, p. 155). 
• Unfortunately, many health 
care providers have not 
acknowledged the life-
saving benefits of the HPV 
vaccine.
• Advanced Practice Nurses 
play a key role in 
“education and advocacy 
for receiving the vaccine” 
(Valentino & Poronsky, 
2015, p. 155).
• APNs must focus their care 
on what affects young 
women: “STI screenings, 
reproductive health needs, 
lifestyle modifications, and 
primary prevention, and risk 
reduction education”  
(Choma & McKeever, 
2015,p 51).
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Nursing Implications
• New studies in cervical 
cancer research illustrate 
that “therapy directed 
toward disrupting function 
of the E6 and E7 oncogenes 
may help reverse aberrant 
DDR signaling that occurs as 
a consequence of HPV 
infection” (Low et all, 2016, 
p.31).
Future 
Research
• The HPV virus is a ”small, 
non-enveloped , double 
stranded DNA virus that 
infects the mucosal or 
cutaneous epithelium”  
(Valentino & Poronsky, 
2015, p. 156). 
• Since HPV affects epithelial 
cells and does not enter the 
bloodstream, “having an 
HPV infection in one part of 
the body should not cause 
infection in another part 
(McCance & Huether, 2014, 
p. 424).
• Once HPV gets into the 
epithelial cell, “the virus 
begins to make proteins that 
can interfere with normal 
functions in the cell, 
enabling the cell to grow in 
an uncontrolled manner and 
to avoid apoptosis” 
(McCance & Huether, 2014, 
p. 424).
Underlying Pathophysiology
• HPV modifies the DNA-
damage response (DDR) 
“pathways by interacting with 
many proteins, including 
ATM, ATR, MRN, y-H2AX, 
Chk1, Chk2, p53, BRCA1, 
BRCA2, RAD51…”(Low et al, 
2016, p. 28). and a few 
others.
• The HPV virus “can activate 
and dysregulate DDR 
pathways throughout various 
stages of their life cycles to 
replicate itself in host cells” 
(Low et al, 2016, p. 29).
• Cell biology during a different 
periods of a woman’s life can 
make her more susceptible to 
contracting the virus (Choma
& McKeever, 2015, p.51).
http://www.cmdrc.com/womens-health/sexually-transmitted-
diseases-std/hpv/.
Screening and Lifestyle 
Modification
• ”Healthy People 2020 has a 
target of 93% for cervical 
cancer screening (Viens et 
al, 2016,p. 665).
• Regular pap smears for 
women aged 21 to 65 are a 
key part of cervical cancer 
screening, which looks for 
precancers. An HPV test can 
also be performed 
(cdc.gov).
• Currently, there are ”no 
recommended screening 
tests for HPV infections in 
young men” (Rigaud, 2015, 
p. 139).
Vaccination
• In 2006, the FDA approved 
the first vaccine against HPV 
(Valentino & Porosnky, 
2015, p. 157).
• According to the CDC, 
“30,000 cases of cancer 
could be prevented with 
HPV vaccination each year” 
(cdc.gov).
• Ideally, this vaccine is given 
prior to any sexual activity.
• The vaccine is given as a 
three series intramuscular 
injection for girls 14-26 and 
for boys 14-21. A two series 
injection is given for boys 
and girls aged 9 to 12 
(cdc.gov).
• In clinical trials, two of the 
vaccines, “Gardasil and 
Cervarix were both found to 
be highly immunogenic…” 
(Valentino & Poronsky, 
2016, p. 157).
https://www.choicesmedical.com/
who-can-get-the-hpv-vaccine-and-
what-does-it-do/
Conclusions
Significance of 
Pathophysiology
• Understanding the 
pathophysiology allows 
for the  development of 
evidence-based 
screening and 
prevention tools, thus 
saving millions of  
healthcare dollars as well 
as thousands of  human 
lives.
• Human papillomavirus is 
a multi-strain virus 
transmitted through 
sexual contact that 
impacts many types of 
people, around the world
• HPV “is a major public 
health concern 
particularly for 
adolescents who are 
disproportionately 
affected” ( Valentino & 
Poronsky, 2015, p. 162).
• Many strains are 
preventable through 
vaccine and others 
through lifestyle 
modifications and safe 
sex practices.
• APNs have a
responsibility to educate 
both men AND women 
and to dispel any myths 
around the vaccine that 
evidence has shown, 
helps to widely decrease 
incidence of the virus.
Signs & Symptoms
• Once infected, many 
patients remain 
asymptomatic and most
cases resolve on their own.
• The virus can remain 
dormant for years and then 
appear untriggered
• Appearance	of	anogenital	warts	or	an	abnormal	pap	smear	are	signs	of	likely		HPV	infection
